sun pharma semaglutide Wins Approval to Launch Generic Wegovy in India Sun Pharmaceutical Industries, India's largest drugmaker by revenue, has received regulatory approval to manufacture and sell a generic version of Novo Nordisk's Now Sun Pharma, Lupin work

Food and Drug Administration (FDA) in 2017 to lower blood sugar levels in adults with type 2 diabetes and obesity by creating more insulin through the pancreas

Clinical trials show that semaglutide's weight-loss benefit accelerates as your dose reaches therapeutic levels and your body adapts to sustained appetite reduction

Rubino et al., Diabetes, Obesity and Metabolism 2025 meta-analysis of GI tolerability across SURMOUNT-1 to -4

PC3 GGT1 + : 1 g

ROS can enhance the production of these cytokines by activating transcription factors like NF-B and AP-1, creating a feed-forward loop that amplifies inflammation and tissue damage

Retatrutide is not approved as a medicine in the UK and is not intended for human or veterinary administration